Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Allogene, Stanford to Develop Better CAR-T Therapies

Allogene Therapeutics inked a research collaboration deal with Stanford University to work on a novel nucleic acid delivery system for CAR-T therapy.

Read More »

Novartis Offers Online Educational Programs to All Employees Via Coursera

Novartis announced a collaboration with online learning platform Coursera to offer educational programs to the company’s staff.

Read More »

AstraZeneca Bolsters Machine Learning for Drug Development with Schrödinger Deal

AstraZeneca struck a deal to use Schrödinger’s advanced computing platform to help accelerate drug discovery efforts.

Read More »

Novartis Inks Collaboration & Option Deal with IFM Due

IFM Therapeutics subsidiary IFM Due and Novartis will develop a group of immunotherapies that inhibit the cGAS/STING pathway to treat a broad range of inflammatory and autoimmune diseases.

Read More »

AbbVie Enters Immuno-Oncology Deal with Idera

Idera Pharmaceuticals announced an immuno-oncology collaboration with AbbVie to evaluate a combination therapy aimed at stimulating the immune system to create an anti-tumor response.

Read More »

Arbitration panel rules in favor of Lilly in complaint filed by Adocia

A Chicago-based arbitration panel ruled in favor of Eli Lilly and Company in a claim filed by Adocia S.A. over the companies’ prior collaboration on a rapid-acting insulin.

Read More »

CureVac and Yale Team Up for mRNA-Based Lung Therapies

Tubingen, Germany-based CureVac entered a collaboration research agreement with Yale University to focus on lung therapies.

Read More »

Harvard, Merck Collaboration Aims to Discover New Immuno-oncology Targets

Harvard University and Merck launched a collaboration that will provide significant research funding for up to four years to support immuno-oncology research led by Arlene Sharpe, MD, PhD, at Harvard Medical School (HMS).

Read More »

GSK ends development of Ebola vaccine, hands work to U.S. institute

GlaxoSmithKline transferred the company’s work on developing three potential vaccines against the Ebola and Marburg viruses.

Read More »

Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence

Syapse, which accelerates precision medicine through insights derived from the company’s global health system network, announced a strategic collaboration with Pfizer Inc. to advance cancer outcomes research using real-world evidence toward the ultimate goal of improving patient health.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom